The NIH, FDA and Bill and Melinda Gates Foundation are working with a San Francisco startup whose calling card is an AI-enabled engine that renders patient data unidentifiable by reproducing it in synthetic versions.
Last Tuesday the FDA posted an action plan telling how it will evaluate AI for medical applications going forward. Three days later the agency officially proposed letting numerous products through without review.
A noted AI researcher and educator who was drawn to the field by its escalating penetration of “the mysteries of perception and cognition” has found a sort of missing link in its evolution.
After perusing info on AI startups as compiled by Crunchbase, Forbes senior contributor Louis Columbus has named one “to watch” in 2021 that serves exclusively healthcare.
The FDA’s new Digital Health Center of Excellence has released a document describing how it will henceforth oversee and evaluate software that incorporates AI and machine learning for medical applications.
